Delivery Order SPE2DR25D2014-SPE2DR26FA0D0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes, with a contract value of $1,647.88 and an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract reflects the firm fixed-price delivery order structure typical of the DLA's pharmaceutical procurement approach. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,159.74 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Naloxone 2 mg/2 mL syringes. The contract is a firm fixed price delivery order with a completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation, reflecting the vendor's capability to meet federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $1,721.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set for ultimate completion by November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.72 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under an existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $3,499.92 delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on October 28, 2025, with completion targeted for October 29, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded a delivery order valued at $15,939.34 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.87 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials. The contract, awarded on November 10, 2025, carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The award represents a competitive procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,093.31 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Naloxone 2mg/2ml in quantities of 10 units, with a ceiling value of $3,593.26. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents performance at the contractor's Conshohocken, Pennsylvania location. This award was not designated as a set-aside contract and was competitively awarded through open competition,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0D0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,129.43 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on December 18, 2025. This non-set-aside, firm fixed-price contract has a completion date of December 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the federal government's critical pharmaceutical supply chain needs, particularly for emergency medical response capabilities across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through open competition across its extensive portfolio of medical product deliveries with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |